Your session is about to expire
← Back to Search
Managing Challenging Behaviors Program for ADHD (MCB-ADHD Trial)
N/A
Waitlist Available
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline, 14 weeks post baseline, and 24 weeks post baseline.
Awards & highlights
MCB-ADHD Trial Summary
This trial tests whether a short, time-limited parent education program can help families of children diagnosed with ADHD and disruptive behaviors. Parents/caregivers will fill out questionnaires to measure changes in behavior, parenting practices and perceptions of mental health care.
Who is the study for?
This trial is for families with children aged 3-8 diagnosed with ADHD or related disruptive behavior disorders, who are patients at the developmental pediatrics clinic in DH Lebanon. The child must be able to speak and not be receiving other outpatient therapy. Families should understand English for in-person or telehealth sessions.Check my eligibility
What is being tested?
The study tests a new short-term educational program aimed at helping parents manage their child's ADHD-related behaviors. It involves comparing a group undergoing a 7-session therapy program against those waiting to receive treatment, measuring changes in behavior, parenting practices, and mental health care perceptions.See study design
What are the potential side effects?
Since this is a psychosocial intervention focusing on education and behavioral management rather than medication, there are no direct medical side effects. However, participants may experience stress or emotional discomfort during the process.
MCB-ADHD Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured at baseline, 14 weeks post baseline, and 24 weeks post baseline.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline, 14 weeks post baseline, and 24 weeks post baseline.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in ADHD-5
Change in Eyberg Child Behavior Inventory
Change in Impairment Rating Scale
+3 moreSecondary outcome measures
Changes in Family Empowerment Scale
Changes in the Barriers to Children's Mental Health Survey
Changes in the Parenting Scale (PS; Rhodes & Leary, 2007).
MCB-ADHD Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Managing Challenging Behaviors in ADHDExperimental Treatment1 Intervention
This is a 7-session behavioral parent training delivered to children ages 3-7 referred to the study after an initial ADHD diagnosis or when challenging behaviors are identified by their medical provider.
Group II: Wait ListActive Control1 Intervention
Families assigned to the wait list will complete measures at baseline, 14 weeks, and 24 weeks. After 24 weeks they will be offered the experimental treatment.
Find a Location
Who is running the clinical trial?
Dartmouth-Hitchcock Medical CenterLead Sponsor
526 Previous Clinical Trials
2,541,215 Total Patients Enrolled
Media Library
Research Study Groups:
This trial has the following groups:- Group 1: Managing Challenging Behaviors in ADHD
- Group 2: Wait List
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does the research project encompass individuals below 30 years of age?
"Per the study's admission parameters, only individuals aged 3 to 8 may enroll in this trial."
Answered by AI
Does this exploratory research still have room for participants?
"According to clinicaltrials.gov, this medical research is recruiting volunteers for participation. Last edited on the 29th of December 2022 and initially posted on October 10th, it continues seeking patient input."
Answered by AI
To what extent is participation in this investigation limited?
"Affirmative. According to information available on clinicaltrials.gov, this medical experiment initiated recruiting on October 10th 2022 and is still searching for study participants. Specifically, 60 individuals are needed from 1 trial site."
Answered by AI
Who else is applying?
What state do they live in?
California
What site did they apply to?
Dartmouth-Hitchcock Medical Center
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger